Medicare, Lung cancer trial results show mortality benefit with low-dose CT
December 12th, 2010
The National Cancer Institute (NCI) is today releasing initial results from a large-scale test of screening methods to reduce deaths from lung cancer by detecting cancers at relatively early stages.
Related posts:
- Lung cancer trial results show mortality benefit with low-dose CT The National Cancer Institute (NCI) is today releasing initial results from a large-scale test of screening methods to reduce deaths from lung cancer by detecting cancers at relatively early stages....
- Funded study shows 20 percent reduction in lung cancer mortality with low-dose CT compared to chest X-ray Scientists have found a 20 percent reduction in deaths from lung cancer among current or former heavy smokers who were screened with low-dose helical computed tomography (CT) versus those screened by chest X-ray. The primary research results from the National Lung Screening Trial (NLST) were published online today in the New England Journal of Medicine. […]...
- Breast Cancer: Rates of New Cases and Deaths Breast Cancer: Rates of New Cases and Deaths ...
- Medicare, New NIH data show gains in COPD awareness The number of Americans who report being aware of chronic obstructive pulmonary disease, or COPD, increased by 4 percentage points between 2008 and 2010, but many people at risk are still unaware of the disease, according to mailed survey results released today by the National Heart, Lung, and Blood Institute (NHLBI), part of the National […]...
- Medicare – Lung Disease the Links to Health People with a mild form of a common lung condition—even those without symptoms—are at increased risk for heart problems, according to a new study. This is the first report that mild, often-symptomless chronic obstructive pulmonary disease (COPD) may be linked to the heart's pumping ability...
- Medicare Report to nation finds continued declines in many cancer rates Rates of death in the United States from all cancers for men and women continued to decline between 2003 and 2007, the most recent reporting period available, according to the latest Annual Report to the Nation on the Status of Cancer. The report also finds that the overall rate of new cancer diagnoses for men […]...
- Medicare Health Checkups – Comparing Models that Assess Breast Cancer Risk A new study found that models for assessing breast cancer risk perform only slightly better when they include common inherited genetic variants recently linked to the disease. For now, recommendations for breast cancer screening or treatments that are based on such models will remain unchanged for most women....
- Secretary Sebelius Statement on New Breast Cancer Recommendations Secretary Sebelius Statement on New Breast Cancer Recommendations...
- Panel Calls for Reducing Colorectal Cancer Deaths by Striking Down Barriers to Screening Colorectal cancer is the second leading cause of cancer-related deaths in the United States. Despite evidence and guidelines supporting the value of screening for this disease, rates of screening for colorectal cancer are consistently lower than those for other types of cancer, particularly breast and cervical. ...
- Medicare Future? Pathways that Can Repair Brca1 Cancer Gene Mutation Clarified in Mice In a new study in mice, scientists have compensated for mutations in the Brca1 gene that can lead to cancer by deleting a second gene, which then lessens the probability of cancer. Mice Brca1-associated mammary tumors have significant similarities to human BRCA1- associated (BReast CAncer 1, early onset) breast cancer in regard to tumor aggressiveness, high incidence, mutations and genetic instability. The study, led by scientists at National Cancer Institute (NCI), part of the National Institutes of Health, and their colleagues, appeared online April 1, 2010 and in print April 16, 2010, in the journal Cell....
- Medicare Card, Scientists Identify Markers, Human Breast Cancer Cells, Linked to Development of an Aggressive, But Less Common Form of Breast Cancer Scientists have identified a group of surface markers on cells linked to an aggressive type of breast cancer called estrogen receptor-negative cancer. In this preliminary study, estrogen-negative breast cancer developed when three markers, CD44+, CD49fhi, and CD133hi were present simultaneously on the surface of human cells taken from breast cancer patients and transplanted into a […]...
- National Cancer Control Month The chances of developing some form of cancer during your lifetime are high, but there are actions you can take to try to protect your health, including cancer screening, not smoking, engaging in physical activity, and eating healthy foods....
- Study ties blood protein to Alzheimer’s brain abnormalities Scientists are seeking ways to detect the earliest stages of Alzheimer’s disease, since harmful changes may be taking place in the brain years before symptoms appear. Now, researchers report that a blood test detecting a specific protein in blood samples from cognitively normal older people may reflect the levels of beta-amyloid protein in the brain […]...
- National Radon Action Month Is a colorless, odorless, deadly gas seeping into your home? Unless you test your home for radon, you’ll never know. It’s estimated that one in 15 homes has elevated levels of radon. Mine did. The amount of radon in the air is measured in Picocuries per Liter, which is abbreviated pCi/L. When I tested our […]...
- Medicare: Independent panel to present findings on role of active surveillance in the management of localized prostate cancer Prostate cancer is the second leading cause of cancer-related deaths among men in the United States. It is estimated that in 2010, approximately 32,000 American men died of prostate cancer and 218,000 were newly diagnosed with the disease....